Dianthus Therapeutics, Inc. /DE/ — All Filings
596 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
RW
S-1
S-1/A
S-3
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001692444-26-000003 | Mar 26, 2026 | Mar 24, 2026 |
| 8-K | 8-K | 0001690585-26-000010 | Mar 26, 2026 | — |
| 144 | — | 0001950047-26-002967 | Mar 24, 2026 | — |
| 4 | 4 | 0001669866-26-000007 | Mar 17, 2026 | Mar 16, 2026 |
| 4 | 4 | 0001669866-26-000005 | Mar 13, 2026 | Mar 12, 2026 |
| 4 | 4 | 0001273351-26-000004 | Mar 13, 2026 | Mar 12, 2026 |
| 4 | 4 | 0001992260-26-000004 | Mar 13, 2026 | Mar 12, 2026 |
| 144 | — | 0001950047-26-002555 | Mar 12, 2026 | — |
| 144 | — | 0001950047-26-002549 | Mar 12, 2026 | — |
| 144 | — | 0001950047-26-002527 | Mar 12, 2026 | — |
| 8-K | 8-K | 0001193125-26-103053 | Mar 12, 2026 | Mar 10, 2026 |
| 424B5 | 424B5 | 0001193125-26-102472 | Mar 11, 2026 | — |
| S-3MEF | S-3MEF | 0001193125-26-100860 | Mar 10, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-098846 | Mar 9, 2026 | — |
| S-8 | S-8 | 0001690585-26-000007 | Mar 9, 2026 | — |
| 10-K | 10-K | 0001690585-26-000006 | Mar 9, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-097555 | Mar 9, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-26-001155 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001346824-26-000039 | Feb 17, 2026 | — |
| 4 | 4 | 0001273351-26-000002 | Feb 4, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001778623-26-000002 | Feb 4, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001992260-26-000002 | Feb 4, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001992324-26-000002 | Feb 4, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001669866-26-000002 | Feb 4, 2026 | Feb 3, 2026 |
| EFFECT | — | 9999999995-26-000432 | Jan 30, 2026 | — |
| S-3 | S-3 | 0001193125-26-027273 | Jan 28, 2026 | — |
| 8-K | 8-K | 0001193125-26-009898 | Jan 12, 2026 | — |
| 4 | 4 | 0001992324-25-000005 | Dec 5, 2025 | Dec 4, 2025 |
| 144 | — | 0001950047-25-009805 | Dec 4, 2025 | — |
| SCHEDULE 13D/A | — | 0001104659-25-116119 | Nov 25, 2025 | — |
| SCHEDULE 13D/A | — | 0000919574-25-007115 | Nov 19, 2025 | — |
| 4 | 4 | 0001992260-25-000008 | Nov 14, 2025 | Nov 13, 2025 |
| SCHEDULE 13G/A | — | 0001214659-25-016717 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001193125-25-283109 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001231919-25-000486 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-005000 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-004823 | Nov 14, 2025 | — |
| 144 | — | 0001950047-25-008824 | Nov 13, 2025 | — |
| SCHEDULE 13G | — | 0000902219-25-000435 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-266920 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-266867 | Nov 5, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002720 | Nov 5, 2025 | — |
| 8-K | 8-K | 0001193125-25-262188 | Nov 3, 2025 | — |
| 8-K | 8-K | 0001193125-25-240858 | Oct 16, 2025 | — |
| 4 | 4 | 0001669866-25-000004 | Oct 3, 2025 | Sep 30, 2025 |
| 4 | 4 | 0001992324-25-000003 | Sep 25, 2025 | Sep 23, 2025 |
| 4 | 4 | 0001992260-25-000005 | Sep 25, 2025 | Sep 23, 2025 |
| SCHEDULE 13D/A | — | 0001104659-25-090015 | Sep 15, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-004074 | Sep 12, 2025 | — |
| 4 | 4 | 0000950170-25-114293 | Sep 11, 2025 | Sep 9, 2025 |